GlassScriptPhysician profile
Michael Nakashian
NPI 1629239645
$2,849.16
in general payments reported to CMS, 2019-2025
19 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 81% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $712 · 2021: $37.54 · 2022: $143 · 2023: $88.02 · 2024: $97.62 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,166 · Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,166.17 |
| Food and Beverage | $645.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,063.36 | 2020-2025 | |
| Arthrex, INC. | $1,034.90 | 2025 | |
| Stryker Corporation | $208.96 | 2022-2025 | Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation |
| Skeletal Dynamics INC | $90.90 | 2019 | |
| Axogen | $60.59 | 2020 | |
| Revance Therapeutics, INC. | $50.27 | 2024 | Daxxify |
| Smith+Nephew, INC. | $44.89 | 2019-2025 | Aetos Shoulder System |
| Endo Pharmaceuticals INC. | $42.68 | 2022 | |
| Depuy Synthes Sales INC. | $39.97 | 2022-2023 | Monovisc, Orthovisc |
| Allergan, INC. | $37.54 | 2021 | |
| Bioventus LLC | $28.32 | 2023 | Durolane |
| Acumed LLC | $26.67 | 2019 | |
| Acera Surgical, INC. | $22.58 | 2025 | Restrata Wound Matrix |
| Linvatec Corporation | $18.68 | 2023 | Biobrace 23mm |
| Djo, LLC | $18.24 | 2025 | Donjoy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $16.28 | 2024 | Exparel |
| Fidia Pharma USA INC. | $15.71 | 2024 | Hymovis |
| Abbott Laboratories | $15.36 | 2024 | Proclaim |
| Sanofi-Aventis U.S. LLC | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nakashian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.